2024 ESC guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the …

C Vrints, F Andreotti, KC Koskinas… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Optimizing management of stable angina: a patient-centered approach integrating revascularization, medical therapy, and lifestyle interventions

RA Montone, R Rinaldi, G Niccoli, G Andò… - Journal of the American …, 2024 - jacc.org
Angina pectoris may arise from obstructive coronary artery disease (CAD) or in the absence
of significant CAD (ischemia with nonobstructed coronary arteries [INOCA]). Therapeutic …

The clinical use of stress echocardiography in chronic coronary syndromes and beyond coronary artery disease: a clinical consensus statement from the European …

E Picano, L Pierard, J Peteiro… - European Heart …, 2024 - academic.oup.com
Since the 2009 publication of the stress echocardiography expert consensus of the
European Association of Echocardiography, and after the 2016 advice of the American …

[HTML][HTML] 2023 Guidelines of the Taiwan Society of Cardiology on the diagnosis and management of chronic coronary syndrome

KC Ueng, CE Chiang, TH Chao, YW Wu… - Acta Cardiologica …, 2023 - ncbi.nlm.nih.gov
Coronary artery disease (CAD) covers a wide spectrum from persons who are asymptomatic
to those presenting with acute coronary syndromes (ACS) and sudden cardiac death …

Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes

F Cinti, L Leccisotti, GP Sorice, U Capece… - Cardiovascular …, 2023 - Springer
Objective We recently demonstrated that treatment with sodium-glucose cotransporter-2
inhibitors (SGLT-2i) leads to an increase in myocardial flow reserve in patients with type 2 …

Continuous versus bolus thermodilution‐derived coronary flow reserve and microvascular resistance reserve and their association with angina and quality of life in …

TPJ Jansen, A de Vos, V Paradies… - Journal of the …, 2023 - Am Heart Assoc
Background Coronary flow reserve (CFR) and microvascular resistance reserve (MRR) are
physiological parameters to assess coronary microvascular dysfunction. CFR and MRR can …

Myocardial interstitial fibrosis in hypertensive heart disease: from mechanisms to clinical management

A González, B López, S Ravassa, G San José… - …, 2024 - Am Heart Assoc
Hypertensive heart disease (HHD) can no longer be considered as the beneficial adaptive
result of the hypertrophy of cardiomyocytes in response to pressure overload leading to the …

Vascular function: a key player in hypertension

H Tomiyama - Hypertension Research, 2023 - nature.com
The major functions of the arterial system are to “efficiently deliver blood to the peripheral
organs and maintain vascular homeostasis”. Both the endothelial and medial layer …

Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes

TTJ Kufazvinei, J Chai, KA Boden… - Cardiovascular …, 2024 - academic.oup.com
After myocardial infarction (MI), patients with type 2 diabetes have an increased rate of
adverse outcomes, compared to patients without. Diabetes confers a 1.5–2-fold increase in …

Coronary microvascular dysfunction is associated with impaired cognitive function: the cerebral-coronary connection study (C3 study)

H Mejia-Renteria, A Travieso… - European heart …, 2023 - academic.oup.com
Background It remains unknown whether the presence of coronary microcirculatory
dysfunction (CMD) correlates with its equivalent condition in the brain, cerebral small vessel …